Inventor
YIN NING
US17 patents
⚠️ This page may combine multiple inventors who share the name “YIN NING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CUBIST PHARM INC
10 patentsUS8809314B1Aug 19, 2014
Cephalosporin compound
CUBIST PHARM INC16 citations82
US8962843B2Feb 24, 2015
1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
CUBIST PHARM INC3 citations72
US8916709B2Dec 23, 2014
1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors
CUBIST PHARM INC4 citations71
US8969570B2Mar 3, 2015
Beta-lactamase inhibitors
CUBIST PHARM INC3 citations61
US8940897B2Jan 27, 2015
1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
CUBIST PHARM INC1 citations61
US8933232B2Jan 13, 2015
1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
CUBIST PHARM INC1 citations61
US8933233B2Jan 13, 2015
1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
CUBIST PHARM INC1 citations61
US8962844B2Feb 24, 2015
1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
CUBIST PHARM INC1 citations60
US8927724B2Jan 6, 2015
Isoxazole beta-lactamase inhibitors
CUBIST PHARM INC3 citations59
US9108966B2Aug 18, 2015
Beta-lactamase inhibitors
CUBIST PHARM INC0 citations50
C4 THERAPEUTICS INC
4 patentsUS11691972B2Jul 4, 2023
Compounds for targeted degradation of BRD9
C4 THERAPEUTICS INC5 citations81
US12157735B2Dec 3, 2024
Compounds for targeted degradation of BRD9
C4 THERAPEUTICS INC1 citations69
US12049464B2Jul 30, 2024
Compounds for targeted degradation of BRD9
C4 THERAPEUTICS INC1 citations69
US12421220B2Sep 23, 2025
Bicyclic-substituted glutarimide cereblon binders
C4 THERAPEUTICS INC0 citations47